Latest news
Loading news…
Arvelle Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Basel, Basel-Stadt, Switzerland Founded 2019 51-100 employees For Profit
Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solution.
Arvelle Therapeutics was acquired by Angelini Pharma in 2021 for $960M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
8
Patents
0
4 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Patents granted
- 0
- Trademarks
- 4
- IT spend
- $429K
Company Info
- Founded
- 2019
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- News articles
- 6
- HQ
- Basel, Basel-Stadt, Switzerland
- Region
- Europe, Middle East, and Africa (EMEA)
- Exit date
- Jan 4, 2021
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- -1
- Trend (90d)
- -0.5
8
professional contacts at Arvelle Therapeutics
Contact execs at Arvelle Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Arvelle Therapeutics
Loading news…
FAQs about Arvelle Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.